Donald Merrihew
Family Medicine · Queensbury, NYNPI 1568444719
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 260 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations.
Across 260 payments — averaging $15.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$600
- GSK$438
- Novo Nordisk$384
- AstraZeneca$309
- Johnson & Johnson$307
- Eisai Inc.$220
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,79697%
- Education$1203%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 48 | $600 |
| GSK | 29 | $438 |
| Novo Nordisk | 27 | $384 |
| AstraZeneca | 22 | $309 |
| Johnson & Johnson | 18 | $307 |
| Eisai Inc. | 14 | $220 |
| Otsuka America Pharmaceutical, Inc. | 13 | $179 |
| Merck | 12 | $159 |
| Orexo US, Inc. | 11 | $154 |
| Astellas Pharma US Inc | 2 | $102 |
| Biohaven Pharmaceuticals, Inc. | 5 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $94 |
| Teva Pharmaceuticals USA, Inc. | 6 | $94 |
| Amgen | 4 | $82 |
| Pfizer | 4 | $74 |
| Esperion Therapeutics, Inc. | 4 | $73 |
| Lilly USA, LLC | 4 | $72 |
| Amarin Pharma, Inc. | 4 | $69 |
| Abbott | 2 | $48 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $46 |
| Kowa Pharmaceuticals America, Inc. | 3 | $44 |
| Novartis | 3 | $43 |
| Lundbeck LLC | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Arbor Pharmaceuticals, Inc. | 2 | $24 |
| Antares Pharma, Inc. | 1 | $21 |
| Seqirus USA Inc | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Medtronic | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
| Melinta Therapeutics, LLC | 1 | $11 |
How this compares
$3,916 in reported general payments places this provider in the 85th percentile of 4,321 family medicine providers in New York.
Other family medicine in Queensbury
- Louis BonavitaEast Syracuse$674K
- Martin MahoneyBuffalo$520K
- Scott BrehautClinton$514K
- David St PeterSaratoga Springs$395K
- Matthew PabisNew York$222K
- Rajveer SachdevPomona$211K
- Eric SchnakenbergHalfmoon$190K
- James NorthGlens Falls$186K
- Eric BatesNew York$171K
- Alexander BlinskiNew York$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.